Dialysis of Drugs 2022 is the essential clinical reference guide for concise, easy-to-use information on the dialyzability of drugs in patients receiving hemodialysis and peritoneal dialysis.
The KDIGO 2022 Clinical Practice Guideline on Diabetes Management in Chronic Kidney Disease is available for public review. This version represents an update to the 2020 guideline and impacts content on comprehensive care and glucose-lowering therapies in patients with type 2 diabetes. KDIGO is accepting comments on this document until March 18, 2022.
On December 1, 2021, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), issued a Request for Information – "Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations (OPOs), and End-Stage Renal Disease (ESRD) Facilities" (CMS-3409-NC) – to solicit stakeholder and public feedback to inform potential changes and future rulemaking to improve the organ transplantation system.
March is National Kidney Month, and March 9 is World Kidney Day. World Kidney Day is a global campaign to raise awareness of the importance of our kidneys to overall health and to reduce the frequency and impact of kidney disease and associated health problems worldwide. The 2023 theme is “Kidney Health for All: Preparing for the Unexpected, Supporting the Vulnerable.”
The American Nurses Association (ANA) is seeking comments on draft documents/topics that will be included in a final report from the National Commission to Address Racism in Nursing. Topics for review include: